Health
Novel nanobody combinations protect cells from SARS-CoV-2 in vitro – Drug Target Review
By combining nanobodies targeting different regions of the SARS-CoV-2 Spike protein, researchers were able to protect cells from infection.
Posted: 14 January 2021 | Hannah Balfour (Drug Target Review) | No comments yet
By combining nanobodies targeting different regions of the SARS-CoV-2 Spike protein, researchers were able to protect cells from infection.
Researchers have developed combined nanobodies which can neutralise SARS-CoV-2, even if it mutates. According to the team, the nanobodies could be developed a drug treatment for use in those critically ill with COVID-19, the disease caused by SARS-CoV-2, or people that may not be…
-
Noosa News17 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General15 hours agoCrowe toasts talkback titan for platforming ‘voiceless’
-
Noosa News16 hours agoQueensland Drug and Alcohol Court provides sentencing options – Proctor
-
General16 hours agoSingapore’s world-first sustainable flights tax will see some Australians pay more to travel